Exploring the optimal range of blood pressure in elderly sepsis patients: a retrospective cohort study based on MIMIC-IV data

探讨老年脓毒症患者的最佳血压范围:一项基于MIMIC-IV数据的回顾性队列研究

阅读:1

Abstract

OBJECTIVE: To explore the optimal range of blood pressure (BP) in elderly sepsis patients. METHODS: A retrospective cohort study was conducted using data from the Medical Information Mart for Intensive Care-IV (MIMIC-IV). Restricted cubic spline (RCS) analysis was employed to examine and visualize the nonlinear relationship between BP and the incidences of in-hospital mortality and atrial fibrillation. Optimal systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP) ranges were identified, and their association with 28-day mortality was validated using Cox regression analysis, propensity score matching (PSM), inverse probability weighting (IPTW), doubly robust model estimation (DR), and Kaplan–Meier survival curves (K-M). RESULTS: A total of 2,253 patients were included. RCS analysis revealed an L-shaped relationship between BP and in-hospital mortality, while the risk of atrial fibrillation increased above certain upper limits. The optimal SBP, DBP and MAP ranges were 108–118, 51–57, and 69–74 mmHg, respectively. Further statistical models confirmed that patients within the optimal BP range were associated with lower 28-day mortality. K–M survival analysis demonstrated that patients within the optimal BP range had a higher probability of survival (All Log-Rank P < 0.05). CONCLUSIONS: This single-center study suggests an optimal BP range for elderly sepsis patients that is associated with reduced 28-day mortality. These findings point to a potential optimal range for hemodynamic management in this population and warrant validation in prospective, multi-center studies. CLINICAL TRIAL: Not applicable. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-025-12255-w.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。